Buys
Open market- Shares
- Avg price
- Total value
William F. Doyle - Executive Chairman, Director at NovoCure Ltd
Issuer-level insider activity
- Role
- Executive Chairman, Director
- Issuer ticker
- NVCR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for William F. Doyle in NovoCure Ltd
Sells
Open market- Shares
- -71,887
- Avg price
- $12.98
- Total value
- -$932,883
Net
Past year- Shares
- -71,887
- Share %
- -100%
- Total value
- -$932,883
Reported holdings for William F. Doyle in NovoCure Ltd
Form 4 holding
Executive Chairman, Director
NovoCure Ltd
- Security class
- Ordinary Shares
- Shares / value
- 328,397
- Estimated value
- $4,409,977
- Report date
- 03 Mar 2026
- Price
- $13.43
- Ownership
- Direct
Form 4 holding
Executive Chairman, Director
NovoCure Ltd
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 288,517
- Estimated value
- Report date
- 03 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for William F. Doyle in NovoCure Ltd
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.